Roth MKM Initiates Coverage On Orthofix Medical with Neutral Rating, Announces Price Target of $12
Portfolio Pulse from Benzinga Newsdesk
Roth MKM analyst Jason Wittes has initiated coverage on Orthofix Medical (NASDAQ:OFIX) with a Neutral rating and a price target of $12.
October 20, 2023 | 9:43 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Orthofix Medical has been given a Neutral rating by Roth MKM analyst Jason Wittes, with a price target of $12.
The Neutral rating from Roth MKM indicates that the analyst believes the stock will perform in line with the market in the near term. The price target of $12 provides a reference point for investors, but does not necessarily indicate a strong bullish or bearish sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100